Sunquest taps Feist as VP of marketing

TriMed Staff | | Health Imaging | Artificial Intelligence

Kelly A. Feist has joined Sunquest Information Systems, a provider of laboratory information systems, as its vice president (VP) of marketing.

In her new marketing role, Feist will be responsible for developing and executing Sunquest’s corporate marketing plans and programs to support its revenue growth and market expansion, according to the Tucson, Ariz.-based company.

Sunquest said that Feist served as senior VP of marketing at Eclipsys, where she was responsible for the execution of corporate marketing functions including: corporate and product messaging, advertising, public relations, trade shows, corporate events and product launches. 

TriMed Staff

Related Content

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.